Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration
- 30 April 2006
- journal article
- Published by Elsevier in Matrix Biology
- Vol. 25 (3), 158-165
- https://doi.org/10.1016/j.matbio.2005.11.003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Studying Gene Function in Eukaryotes by Conditional Gene InactivationAnnual Review of Genetics, 2002
- Mouse α1(I)‐collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblastDevelopmental Dynamics, 2002
- Characterization and expression of murine PRELPMatrix Biology, 2001
- Site- and Time-Specific Gene Targeting in the MouseMethods, 2001
- Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinasesNucleic Acids Research, 1999
- Spatio-temporally controlled site-specific somatic mutagenesis in the mouseProceedings of the National Academy of Sciences, 1997
- Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potentialNucleic Acids Research, 1997
- Ligand-activated site-specific recombination in mice.Proceedings of the National Academy of Sciences, 1996
- Transcriptional Activation by Tetracyclines in Mammalian CellsScience, 1995
- Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proceedings of the National Academy of Sciences, 1992